FFP104
/ FF Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 03, 2016
A Pilot Study of FFP104 in Subjects With Crohn's Disease
(clinicaltrials.gov)
- P2; N=24; Recruiting; Sponsor: Fast Forward Pharmaceuticals; Not yet recruiting ➔ Recruiting; Initiation date: Sep 2015 ➔ Jan 2016
Enrollment open • Trial initiation date • Biosimilar • Crohn's Disease • Immunology • Inflammation • Inflammatory Bowel Disease
1 to 1
Of
1
Go to page
1